David Lanar
5Patents
2h-index
9Co-inventors
36Inventor score
Filing activity: Mar 18, 2002 → May 14, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7029685B2 | Plasmodium falciparum AMA-1 protein and uses thereof | Emerging Cross-Sectional Technologies | 29 | Expired |
| US7060276B2 | Plasmodium falciparum AMA-1 protein and uses thereof | Emerging Cross-Sectional Technologies | 28 | Expired |
| US7550275B2 | Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide | Emerging Cross-Sectional Technologies | 0 | Expired |
| US8268615B2 | Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide | Emerging Cross-Sectional Technologies | 0 | Active |
| US7150875B2 | Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.